Stay updated on OPTIM Study: Immunotherapy in Head and Neck Clinical Trial
Sign up to get notified when there's something new on the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page.

Latest updates to the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page
- Check3 days agoChange DetectedThe footer's site revision identifier updates from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check10 days agoChange DetectedA notice appears above the error page announcing NIH website updates and saying federal agencies are using “Super Intelligence” instead of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check17 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the study record remains inaccessible behind a 403 Forbidden page.SummaryDifference0.2%

- Check24 days agoChange DetectedThe site revision label in the footer changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now shows a 403 Forbidden error, with only basic navigation visible, and the detailed study content has been removed from view, indicating the record is currently inaccessible rather than updated content.SummaryDifference19%

- Check66 days agoChange DetectedThe page adds a new funding line for 2017 (U.S. NIH Grant/Contract) and updates the revision to v3.6.6, replacing v3.6.5.SummaryDifference0.1%

Stay in the know with updates to OPTIM Study: Immunotherapy in Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OPTIM Study: Immunotherapy in Head and Neck Clinical Trial page.